Anterior Hypopituitarism in Adult Survivors of Childhood Cancers Treated With Cranial Radiotherapy: A Report From the St Jude Lifetime Cohort Study BAL may be the preferred diagnostic modality for the ...

The lung is a frequent site of infection in patients receiving treatment for malignancy. This occurs in up to 20% of cases and has a quoted mortality rate of 55–90%. 1,2 Although infection is the ...

A prospective study was performed on consecutive patients who were admitted to the Haematopoietic stem cell transplant unit at Newcastle General Hospital between January 2002 and April 2006 for HSCT ...

The diagnosis and treatment of bacterial pneumonia in patients who are receiving mechanical ventilation remain a difficult challenge. The triggering receptor expressed on myeloid cells (TREM-1) is a ...

Critically ill patients who require mechanical ventilation are at risk for ventilator-associated pneumonia. Current data are conflicting as to the optimal diagnostic approach in patients who have ...

The assessment of patients with non-neoplastic lung diseases requires a multidisciplinary approach with evaluation of clinical, radiologic, and pathologic parameters. This chapter will review general ...

Pneumonia remains a major cause of morbidity and mortality. The use of broad-spectrum antibiotics is associated with the development of resistance, major side-effects and costs. Despite a higher ...

A new study compared BAL cell-free DNA (cfDNA) sequencing against plasma cell-free BAL sequencing to detect lung cancer-derived mutations. The BAL cfDNA approach detected ≥1 tumor-derived mutation in ...

The etiology of hypersensitivity pneumonitis (HP) is specific allergen–driven, while in sarcoidosis it is a subject of research and speculations. However, both diseases share a common pathogenesis, ...

INTRODUCTION: In the pathogenesis of diffuse parenchymal lung diseases (DPLDs), growth factors, including transforming growth factor β1 (TGF-β1), are responsible for cell proliferation, apoptosis, ...

Today, “bronchoalveolar carcinoma” is an obsolete term. In 2011, leading international and U.S. lung health organizations restructured the classification system of a group of lung cancers called ...